Aortic Valve Disease Clinical Trials
2 recruiting trials for Aortic Valve Disease. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Aortic Valve Disease clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Second Affiliated Hospital, School of Medicine, Zhejiang University (1), Université Libre de Bruxelles (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Kinocardiography (diagnostic_test, 1 trial).
Track Aortic Valve Disease trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Prospective Observational Cohort Study of Moderate Aortic Valve Disease
The objective of this research is to evaluate and predict the progression of moderate aortic stenosis and regurgitation from clinical characterization, biological,...
Aortopathy Relationship To Imagery and Kinocardiography Features (ARTIK)
Kinocardiography (KCG) is a portable measurement technique developed to estimate cardiac mechanical performance by studying the vibrations produced by myocardial contraction...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Aortic Valve Disease, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Aortic Valve Disease, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Aortic Valve Disease, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.